ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS

The aim of our study was to evaluate a risk reduction of indigenous gut microbiota in patients with urinary tract infection (UTI, associated with the intake of antibacterial medicinal products Materials and methods. To this retrospective cohort case-control study were involved 233 women with UTI...

Full description

Bibliographic Details
Main Authors: N. Stepanova, N. Stashevska, L. Lebid, S. Savchenko, M. Kolesnyk
Format: Article
Language:English
Published: National Kidney Foundation of Ukraine 2017-06-01
Series:Український Журнал Нефрології та Діалізу
Subjects:
Online Access:https://ukrjnd.com.ua/index.php/journal/article/view/223
_version_ 1827265300549074944
author N. Stepanova
N. Stashevska
L. Lebid
S. Savchenko
M. Kolesnyk
author_facet N. Stepanova
N. Stashevska
L. Lebid
S. Savchenko
M. Kolesnyk
author_sort N. Stepanova
collection DOAJ
description The aim of our study was to evaluate a risk reduction of indigenous gut microbiota in patients with urinary tract infection (UTI, associated with the intake of antibacterial medicinal products Materials and methods. To this retrospective cohort case-control study were involved 233 women with UTI. The mean age in the patient population was 36.7 ± 15.6 years. Cases were defined as reducing the number of Lactobacillus spp. < 10 million colony forming units in 1 g offeces (mln. CFU/g). We evaluated the daily urinary oxalate excretion and bacteriological seeding feces. Investigational antibiotics were medicines which are generally used to treat the outpatient with UTI. Results. The data analysis demonstrated an extremely high risk the reducing of Lactobacillus spp. colonization in the patient’s intestine. The use of ciprofloxacin was significantly associated with an availability of hyperoxaluria ( = 0.31, p = 0.008). Conclusions. Thus, the use of antibacterial medicinal products, even in prophylactic doses, by the patients with UTI leads to the destruction of the normal composition of gut microbiota, and, primarily, due to the fact that the content of Lactobacillus spp. is deceased.
first_indexed 2024-04-24T23:41:13Z
format Article
id doaj.art-5cb7ad51c14f4e66b79a03024eab838a
institution Directory Open Access Journal
issn 2304-0238
2616-7352
language English
last_indexed 2025-03-22T03:59:46Z
publishDate 2017-06-01
publisher National Kidney Foundation of Ukraine
record_format Article
series Український Журнал Нефрології та Діалізу
spelling doaj.art-5cb7ad51c14f4e66b79a03024eab838a2024-04-28T10:37:28ZengNational Kidney Foundation of UkraineУкраїнський Журнал Нефрології та Діалізу2304-02382616-73522017-06-012(54)10.31450/ukrjnd.2(54).2017.05223ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONSN. Stepanova0N. Stashevska1L. Lebid2S. Savchenko3M. Kolesnyk4SI «Institute of Nephrology NAMS of Ukraine»SI «Institute of Nephrology NAMS of Ukraine»National Academy of Statistics, Accounting and AuditSI «Institute of Nephrology NAMS of Ukraine»SI «Institute of Nephrology NAMS of Ukraine» The aim of our study was to evaluate a risk reduction of indigenous gut microbiota in patients with urinary tract infection (UTI, associated with the intake of antibacterial medicinal products Materials and methods. To this retrospective cohort case-control study were involved 233 women with UTI. The mean age in the patient population was 36.7 ± 15.6 years. Cases were defined as reducing the number of Lactobacillus spp. < 10 million colony forming units in 1 g offeces (mln. CFU/g). We evaluated the daily urinary oxalate excretion and bacteriological seeding feces. Investigational antibiotics were medicines which are generally used to treat the outpatient with UTI. Results. The data analysis demonstrated an extremely high risk the reducing of Lactobacillus spp. colonization in the patient’s intestine. The use of ciprofloxacin was significantly associated with an availability of hyperoxaluria ( = 0.31, p = 0.008). Conclusions. Thus, the use of antibacterial medicinal products, even in prophylactic doses, by the patients with UTI leads to the destruction of the normal composition of gut microbiota, and, primarily, due to the fact that the content of Lactobacillus spp. is deceased. https://ukrjnd.com.ua/index.php/journal/article/view/223lactobacilli, intestine, antibacterial drugs, hyperoxaluria.
spellingShingle N. Stepanova
N. Stashevska
L. Lebid
S. Savchenko
M. Kolesnyk
ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS
Український Журнал Нефрології та Діалізу
lactobacilli, intestine, antibacterial drugs, hyperoxaluria.
title ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS
title_full ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS
title_fullStr ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS
title_full_unstemmed ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS
title_short ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS
title_sort antibiotic associated risk the reduction of lactobacillus spp in the intestinal microbiota in patients with urinary tract infections
topic lactobacilli, intestine, antibacterial drugs, hyperoxaluria.
url https://ukrjnd.com.ua/index.php/journal/article/view/223
work_keys_str_mv AT nstepanova antibioticassociatedriskthereductionoflactobacillussppintheintestinalmicrobiotainpatientswithurinarytractinfections
AT nstashevska antibioticassociatedriskthereductionoflactobacillussppintheintestinalmicrobiotainpatientswithurinarytractinfections
AT llebid antibioticassociatedriskthereductionoflactobacillussppintheintestinalmicrobiotainpatientswithurinarytractinfections
AT ssavchenko antibioticassociatedriskthereductionoflactobacillussppintheintestinalmicrobiotainpatientswithurinarytractinfections
AT mkolesnyk antibioticassociatedriskthereductionoflactobacillussppintheintestinalmicrobiotainpatientswithurinarytractinfections